Evaxion A (EVAX) Non-cash Items (2020 - 2025)
Evaxion A (EVAX) reported Non-cash Items of -$1.6 million for Q2 2025, up 53.34% on a YoY basis from -$1.0 million in Q2 2024, and up 53.34% quarter-over-quarter from -$3.4 million in Q2 2024.
Evaxion A (EVAX) Non-cash Items (2020 - 2025) Analysis & Trends
Evaxion A has reported Non-cash Items for 6 years, with the latest figure at -$1.6 million in Q2 2025.
- For the quarter ending Q2 2025, Non-cash Items rose 53.34% year-over-year to -$1.6 million; the trailing twelve-month figure through Jun 2025 stood at -$1.6 million (up 53.34% YoY), and the FY2024 full-year result was -$3.1 million, down 360.62% from the prior year.
- Non-cash Items for Q2 2025 stood at -$1.6 million, up from -$3.4 million in the prior quarter.
- The five-year high for Non-cash Items was $717000.0 in Q2 2023, with the low at -$3.4 million in Q2 2024.
- Historically, Non-cash Items has averaged -$1.0 million across 5 years, with a median of -$963500.0 in 2021.
- Annual changes were most pronounced in 2023 — Non-cash Items soared 175.55% — and 2024, when it plunged 577.96%.
- Evaxion A's Non-cash Items stood at -$1.0 million in 2021, then increased by 9.27% to -$949000.0 in 2022, then soared by 175.55% to $717000.0 in 2023, then sank by 577.96% to -$3.4 million in 2024, then soared by 53.34% to -$1.6 million in 2025.
- The last three Non-cash Items figures came in at -$1.6 million (Q2 2025), -$3.4 million (Q2 2024), and $717000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1.60 Mn |
| Jun 30, 2025 | -1.60 Mn |
| Jun 30, 2024 | -3.43 Mn |
| Jun 30, 2024 | -3.43 Mn |
| Jun 30, 2023 | 717,000.00 |
| Jun 30, 2023 | 717,000.00 |
| Jun 30, 2022 | -949,000.00 |
| Jun 30, 2022 | -949,000.00 |
| Mar 31, 2022 | -129,000.00 |
| Mar 31, 2022 | -129,000.00 |
| Sep 30, 2021 | -1.05 Mn |
| Sep 30, 2021 | -1.05 Mn |
| Jun 30, 2021 | -908,000.00 |
| Jun 30, 2021 | -908,000.00 |
| Mar 31, 2021 | -978,000.00 |
| Mar 31, 2021 | -978,000.00 |
| Sep 30, 2020 | 1.81 Mn |
| Sep 30, 2020 | 1.81 Mn |
| Jun 30, 2020 | 735,000.00 |
| Jun 30, 2020 | 735,000.00 |